Effects of High-Resolution Natural Sound with Inaudible High-Frequency Components on Healing, Symptoms, and Sleep Satisfaction in Terminally Ill Cancer Patients.
{"title":"Effects of High-Resolution Natural Sound with Inaudible High-Frequency Components on Healing, Symptoms, and Sleep Satisfaction in Terminally Ill Cancer Patients.","authors":"Yasutaka Shimotsuura, Keisuke Ishizuka, Takashi Kawaguchi, Kazue Umetsu, Mariko Harada, Yujiro Inoue, Emi Kubo, Kazuhiro Kosugi, Takashi Igarashi, Seiya Enomoto, Hidehiko Taniyama, Tetsuo Iwata, Takuhiro Yamaguchi, Yoshihisa Matsumoto, Tomofumi Miura","doi":"10.1089/pmr.2024.0089","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to assess the effects of high-resolution natural sound with inaudible high-frequency components (HNIH) on healing, symptoms, sleep satisfaction, and autonomic nerve function among terminally ill cancer patients.</p><p><strong>Methods: </strong>We conducted a single-arm, open-label study of 4-hour HNIH for 20 terminally ill cancer patients. We evaluated the healing state, symptoms (Japanese version of the Edmonton Symptom Assessment System-Revised, ESAS-r-J), global impression, and heart rate variability at 30 minutes (T2) and 4 hours (T3) after starting HNIH and sleep satisfaction the next morning (T4).</p><p><strong>Results: </strong>A total of 18 participants were evaluated (mean age: 69.4 years; 33.3% female). Post-intervention, there was a nonsignificant increase in Healing Scale scores at T2 (mean difference: 5.3, 95% confidence interval [CI]: -1.2 to 11.8, <i>p</i> = 0.106), but a significant increase at T3 (mean difference: 6.6, 95% CI: 1.0 to 12.3, <i>p</i> = 0.024). Specific ESAS-r-J scores demonstrated significant improvements in anxiety (mean difference at T2: -1.2, 95% CI: -1.99 to -0.34, <i>p</i> = 0.008; T3: -1.2, 95% CI: -1.99 to -0.34, <i>p</i> = 0.008), tiredness (mean difference at T2: -0.6, 95% CI: -1.18 to -0.04, <i>p</i> = 0.037), and shortness of breath (mean difference at T2: -1.0, 95% CI: -1.72 to -0.28, <i>p</i> = 0.010). Moreover, 66.7% of participants reported improved general conditions at T2 and T3, whereas 50% reported enhanced sleep satisfaction at T4. Heart rate variability analysis revealed a decreased low-frequency/high-frequency ratio in 55.6% of participants at T2 and 44.4% at T3.</p><p><strong>Conclusions: </strong>The present single-arm study showed that HNIH potentially enhanced healing, alleviated symptoms such as anxiety, tiredness, and shortness of breath, and improved sleep satisfaction in terminally ill cancer patients.</p>","PeriodicalId":74394,"journal":{"name":"Palliative medicine reports","volume":"6 1","pages":"53-60"},"PeriodicalIF":1.1000,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11947647/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Palliative medicine reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/pmr.2024.0089","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: This study aimed to assess the effects of high-resolution natural sound with inaudible high-frequency components (HNIH) on healing, symptoms, sleep satisfaction, and autonomic nerve function among terminally ill cancer patients.
Methods: We conducted a single-arm, open-label study of 4-hour HNIH for 20 terminally ill cancer patients. We evaluated the healing state, symptoms (Japanese version of the Edmonton Symptom Assessment System-Revised, ESAS-r-J), global impression, and heart rate variability at 30 minutes (T2) and 4 hours (T3) after starting HNIH and sleep satisfaction the next morning (T4).
Results: A total of 18 participants were evaluated (mean age: 69.4 years; 33.3% female). Post-intervention, there was a nonsignificant increase in Healing Scale scores at T2 (mean difference: 5.3, 95% confidence interval [CI]: -1.2 to 11.8, p = 0.106), but a significant increase at T3 (mean difference: 6.6, 95% CI: 1.0 to 12.3, p = 0.024). Specific ESAS-r-J scores demonstrated significant improvements in anxiety (mean difference at T2: -1.2, 95% CI: -1.99 to -0.34, p = 0.008; T3: -1.2, 95% CI: -1.99 to -0.34, p = 0.008), tiredness (mean difference at T2: -0.6, 95% CI: -1.18 to -0.04, p = 0.037), and shortness of breath (mean difference at T2: -1.0, 95% CI: -1.72 to -0.28, p = 0.010). Moreover, 66.7% of participants reported improved general conditions at T2 and T3, whereas 50% reported enhanced sleep satisfaction at T4. Heart rate variability analysis revealed a decreased low-frequency/high-frequency ratio in 55.6% of participants at T2 and 44.4% at T3.
Conclusions: The present single-arm study showed that HNIH potentially enhanced healing, alleviated symptoms such as anxiety, tiredness, and shortness of breath, and improved sleep satisfaction in terminally ill cancer patients.